Prometheus Biosciences, Inc. Quarterly Debt-to-equity in % from Q3 2021 to Q1 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Prometheus Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q3 2021 to Q1 2023.
  • Prometheus Biosciences, Inc. Debt-to-equity for the quarter ending March 31, 2023 was 13.2 %, a 4.97% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2023 13.2 -0.69 -4.97% Mar 31, 2023
Q4 2022 17.1 +6.91 +67.8% Dec 31, 2022
Q3 2022 22.1 +7.56 +52% Sep 30, 2022
Q2 2022 17 Jun 30, 2022
Q1 2022 13.9 Mar 31, 2022
Q4 2021 10.2 Dec 31, 2021
Q3 2021 14.5 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.